Print Page | Contact Us | Report Abuse | Sign In | Register
Graphene Updates
Blog Home All Blogs
Search all posts for:   

 

View all (44) posts »
 

Graphene enables a test for cancer that is faster, more accurate and less expensive!

Posted By Terrance Barkan, Monday, October 16, 2017

An international team of researchers led by Professor Steven Conlan, Swansea University Medical School and the Centre for NanoHealth has won an international award for a graphene biosensor based diagnostic test for ovarian cancer which is quicker, more accurate, less expensive and portable.

The team developed a testing device which can diagnose ovarian cancer in a few minutes using a drop of blood. This portable technology is different from the ones currently in the hospital environment and allows for greater flexibility in terms of monitoring a patient even after she has already been diagnosed with ovarian cancer.

As well as the test being simple and fast the test does not require a technically-developed laboratory or a specialized technician to operate it which reduces costs and means that there isn’t a need for a centralisation of services. The device can also be used with other biomarkers to detect other types of disease.

Ovarian cancer research award ‌Professor Conlan, together with colleagues Dr Sofia Teixeira (Swansea University College of Engineering), Drs Lewis Francis, Deya Gonzalez and Lavinia Margarit (from the Swansea University Medical School), and Dr Ines Pinto from the International Iberian Nanotechnology Laboratory, INL, Braga, Portugal have been recognised for their pioneering work with the award of the i3S Hovine Capital Health Innovation prize.
 
Professor Conlan said: “The Hovione prize will allow the team to initiate the process of moving our device from the lab to the patient. Whilst there is much work to be done, this is an important step towards the better and earlier diagnosis of patients with ovarian cancer. Cooperation between the two European centres has been key in realising this achievement.”

i3S Hovine Capital Health Innovation prize, created this year, aims at distinguishing innovative ideas in the area of health. The winners of the grand prize receive €35,000 in financing and services that include a market study, development of a business plan, technology validation by industrial experts, and support in setting up a company based on the winning technology.

The i3S-Hovione Capital Health Innovation Prize is supported internationally by the European Institute of Innovation and Technology (EIT-Health) and has partnerships with several entities, such as Bluecinical (PT), Patentree (PT), SRS Advogados (PT), Impact Science (UK), and ANI / MCTES (PT) through its Bfk Award.

Tags:  Biosensor  Cancer  Graphene  Healthcare  Medical 

Share |
Permalink | Comments (0)